Melatonin and the Prevention and Management of Delirium: A Scoping Study
- PMID: 29376051
- PMCID: PMC5767075
- DOI: 10.3389/fmed.2017.00242
Melatonin and the Prevention and Management of Delirium: A Scoping Study
Abstract
Background: The therapeutic benefit of melatonin in the prevention and treatment of delirium is uncertain.
Objective: To perform a scoping study to describe the existing literature regarding the use of melatonin and ramelteon in the prevention and treatment of delirium.
Methods: We performed a scoping study using the Arksey and O'Malley framework to explore our objective. Two independent panels searched MEDLINE, OVID, EMBASE, PubMed, Google Scholar, and Cochrane Library for relevant articles up to November 2017 describing the use of melatonin and ramelteon in the prevention or management of delirium. We extracted relevant summary data from the studies and attempted to draw conclusion regarding benefit.
Results: We summarized evidence from 20 relevant articles. There were a total of nine articles: five randomized controlled trials (RCTs), two retrospective medical record reviews, one non-randomized observational study, and one case report describing the role of either melatonin or ramelteon in preventing delirium. There were a total of 11 studies studying the role of either melatonin or ramelteon in the management of established delirium. None of these were RCT and were predominantly case series and case reports. Four of the five trials studying the effect of melatonin analogs in preventing delirium reported a beneficial effect but study heterogeneity limited any broad recommendations. Similarly, the lack of any well-designed trials limits any recommendations regarding the effect of melatonin analogs in treating delirium.
Conclusion: Large, well-designed clinical trials are required to explore the potential beneficial effects of melatonin and ramelteon on delirium prevention and management.
Keywords: delirium; management; melatonin; melatonin agonist; prevention; ramelteon.
Figures
Similar articles
-
Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.Curr Neuropharmacol. 2022;20(10):1956-1968. doi: 10.2174/1570159X20666220507024219. Curr Neuropharmacol. 2022. PMID: 35524672 Free PMC article.
-
Melatonin and melatonin agonist for delirium in the elderly patients.Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):119-29. doi: 10.1177/1533317514539379. Epub 2014 Jun 18. Am J Alzheimers Dis Other Demen. 2015. PMID: 24946785 Free PMC article. Review.
-
Melatonin for delirium prevention in hospitalized patients: A systematic review and meta-analysis.J Psychiatr Res. 2021 Jan;133:181-190. doi: 10.1016/j.jpsychires.2020.12.020. Epub 2020 Dec 13. J Psychiatr Res. 2021. PMID: 33348252
-
Melatonin Receptor Agonists for Delirium Prevention.Ann Pharmacother. 2017 Jan;51(1):72-78. doi: 10.1177/1060028016665863. Epub 2016 Aug 20. Ann Pharmacother. 2017. PMID: 27539735 Review.
-
Melatonin for the prevention of postoperative delirium in older adults: a systematic review and meta-analysis.BMC Geriatr. 2019 Oct 16;19(1):272. doi: 10.1186/s12877-019-1297-6. BMC Geriatr. 2019. PMID: 31619178 Free PMC article.
Cited by
-
State of the clinical science of perioperative brain health: report from the American Society of Anesthesiologists Brain Health Initiative Summit 2018.Br J Anaesth. 2019 Oct;123(4):464-478. doi: 10.1016/j.bja.2019.07.004. Epub 2019 Aug 19. Br J Anaesth. 2019. PMID: 31439308 Free PMC article. Review.
-
Melatonin to prevent delirium in patients with advanced cancer: a double blind, parallel, randomized, controlled, feasibility trial.BMC Palliat Care. 2020 Oct 21;19(1):163. doi: 10.1186/s12904-020-00669-z. BMC Palliat Care. 2020. PMID: 33087111 Free PMC article. Clinical Trial.
-
Melatonin intervention to prevent delirium in hospitalized patients: A meta-analysis.World J Clin Cases. 2022 Apr 26;10(12):3773-3786. doi: 10.12998/wjcc.v10.i12.3773. World J Clin Cases. 2022. PMID: 35647160 Free PMC article.
-
Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.Curr Neuropharmacol. 2022;20(10):1956-1968. doi: 10.2174/1570159X20666220507024219. Curr Neuropharmacol. 2022. PMID: 35524672 Free PMC article.
-
Management of Post-Liver-Transplant Delirium with Melatonin: A Case Report.Indian J Psychol Med. 2021 Sep;43(5):454-456. doi: 10.1177/0253717620935577. Epub 2020 Jul 14. Indian J Psychol Med. 2021. PMID: 34584315 Free PMC article. No abstract available.
References
-
- APA. Diagnostic and Statistical Manual of Mental Disorders. Text Revision (DSM-IV-TR). 4th ed Arlington, VA: American Psychiatric Press; (2000). p. 553–7.
LinkOut - more resources
Full Text Sources
Other Literature Sources